Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.

AUTOR(ES)

Takada, K

RESUMO

Endotoxin (lipopolysaccharide [LPS]) released during gram-negative bacterial infection induces varieties of cytokines which directly and/or indirectly cause shock, disseminated intravascular coagulation, and death. We previously showed that lysozyme (LZM) was an LPS-binding protein and inhibited various immunomodulating activities of LPS. In this study, we examined the effect of LZM on the LPS-triggered septic shock model induced by carrageenan treatment and assessed by tumor necrosis factor production. The data presented in this report strongly suggest that LZM-LPS complex formation completely abrogates tumor necrosis factor production and the mortality caused by LPS and that LZM may be useful for the treatment of endotoxin shock.

Documentos Relacionados

• Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.
• Colchicine prevents tumor necrosis factor-induced toxicity in vivo.
• Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.
• Carrageenan Primes Leukocytes To Enhance Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production
• Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.